Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors

D Dai, DM Wolf, ES Litman, MJ White, KK Leslie - Cancer research, 2002 - AACR
Progesterone is a critical steroid hormone that controls cell proliferation and differentiation
in the female reproductive tract. Progesterone acts through two nuclear receptor isoforms, …

[HTML][HTML] G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth

WK Petrie, MK Dennis, C Hu, D Dai… - Obstetrics and …, 2013 - hindawi.com
Endometrial carcinoma is the most common cancer of the female reproductive tract. GPER/GPR30
is a 7-transmembrane spanning G protein-coupled receptor that has been identified …

Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG

LA Cole, D Dai, SA Butler, KK Leslie, EI Kohorn - Gynecologic Oncology, 2006 - Elsevier
OBJECTIVE.: Hyperglycosylated hCG (hCG-H) is a glycosylation variant of hCG produced by
cytotrophoblast cells at implantation of pregnancy and in choriocarcinoma. We investigated …

[HTML][HTML] TP53 oncomorphic mutations predict resistance to platinum‑and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian …

…, AM Button, SL Mott, D Dai… - international …, 2015 - spandidos-publications.com
Individual mutations in the tumor suppressor TP53 alter p53 protein function. Some mutations
create a non‑functional protein, whereas others confer oncogenic activity, which we term ‘…

[HTML][HTML] Inverse relationship between progesterone receptor and Myc in endometrial cancer

T Kavlashvili, Y Jia, D Dai, X Meng, KW Thiel… - PloS one, 2016 - journals.plos.org
Endometrial cancer, the most common gynecologic malignancy, is a hormonally-regulated
disease. Response to progestin therapy positively correlates with hormone receptor …

Identification of a novel mechanism of NF-κB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells …

S Davies, D Dai, I Feldman, G Pickett, KK Leslie - Gynecologic oncology, 2004 - Elsevier
Objective. Nuclear factor kappa B (NFκB) is a strong anti-apoptotic factor, which is constitutively
active in human endometrial cancer cells. Progesterone is the principal growth inhibitory …

[HTML][HTML] Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer

…, EJ Devor, AM Hovey, HD Reyes, X Xiao, Y Xu, D Dai… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Progesterone, acting through its receptor, PR (progesterone receptor), is the natural inhibitor
of uterine endometrial carcinogenesis by inducing differentiation. PR is downregulated in …

Regression of the decidualized mesometrium and decidual cell apoptosis are associated with a shift in expression of Bcl2 family members

D Dai, BC Moulton, TF Ogle - Biology of reproduction, 2000 - academic.oup.com
The purpose of this study was to determine whether regression of the decidua basalis (DB),
which begins on Day 14 of pregnancy in the rat, results from an intrinsic program of …

Progesterone receptor isoform identification and subcellular localization in endometrial cancer

KK Leslie, MP Stein, NS Kumar, D Dai, J Stephens… - Gynecologic …, 2005 - Elsevier
OBJECTIVE: These studies were undertaken to characterize the subcellular localization of
the two major isoforms of progesterone receptors (PR), PRA and PRB, in endometrial cancer. …

Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53

…, S Yang, Z Xiong, D Zhu, X Wang, D Dai… - Gynecologic …, 2013 - Elsevier
OBJECTIVE: Endometrial tumors with non-functional p53, such as serous uterine endometrial
carcinomas, are aggressive malignancies with a poor outcome, yet they have an Achilles' …